You searched for: lenalidomide (Engelska - Estniska)

lenalidomide
lenalidomiid

lenalidomide arm
lenalidomiidi rühm

revlimid lenalidomide
revlimid lenalidomiid

discontinuation of lenalidomide
ravi lõpetamine lenalidomiidiga

lenalidomide (25 mg) oral
lenalidomiid (25 mg), suukaudne

interrupt lenalidomide treatment
katkestada ravi lenalidomiidiga

empliciti + lenalidomide and dexamethasone
empliciti + lenalidomiid ja deksametasoon

the active substance is lenalidomide.
toimeaine on lenalidomiid.

revlimid 10 mg hard capsules lenalidomide
revlimid 10 mg kõvakapslid lenalidomiid

each capsule contains 10 mg lenalidomide.
iga kapsel sisaldab 10 mg lenalidomiidi.

each capsule contains 10 mg of lenalidomide.
iga kapsel sisaldab 10 mg lenalidomiidi.

kyprolis in combination with lenalidomide and dexamethasone
kyprolis kombinatsioonis lenalidomiidi ja deksametasooniga

lenalidomide is produced as a racemic mixture.
lenalidomiidi toodetakse ratseemilise seguna.

carcinogenicity studies with lenalidomide have not been conducted.
kartsinogeensuse uuringuid lenalidomiidiga läbi viidud ei ole.

brief background on lenalidomide and its licensed indication
lühike taustateave lenalidomiidi ja selle kinnitatud näidustuse kohta

revlimid contains the active substance ‘lenalidomide’.
revlimid sisaldab toimeainena lenalidomiidi.

fall to < 25 x 109/l interrupt lenalidomide treatment
langeb < 25 x 109/l katkestada ravi lenalidomiidiga

pregnancy warning lenalidomide is structurally related to thalidomide.
hoiatus raseduse korral lenalidomiid on struktuuri poolest sarnane talidomiidiga.

gastrointestinal perforations have been reported during treatment with lenalidomide.
ravi ajal lenalidomiidiga on teatatud seedetrakti perforatsioonidest.

first fall to < 30 x 109/l interrupt lenalidomide treatment
esmalt langeb < 30 x 109/l katkestada ravi lenalidomiidiga